Nifty 50
- Apollo Hospitals₹8,027.50361.50 (4.72%)
- BSE₹3,287.20-47.60 (-1.43%)
- ITC₹26611.00 (4.31%)
- Reliance Industries₹1,170.30-7.70 (-0.65%)
- Eicher Motors₹7,050282.50 (4.17%)
- JSW Steel₹1,168-7.20 (-0.61%)
- TCS₹2,15680.00 (3.85%)
- Cipla₹1,301-5.80 (-0.44%)
- HCL Technologies₹1,216.7039.80 (3.38%)
- Adani Ports₹1,76153.00 (3.10%)
- Infosys₹1,023.4026.40 (2.65%)
- Shriram Finance₹940.4523.20 (2.53%)
- Tata Motors PV₹279.906.90 (2.53%)
- UltraTech Cement₹10,675249.00 (2.39%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
GlaxoSmithKline Share Price Today
As of 09-10-2026 04:29, GlaxoSmithKline Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-2534.40 (-100.00%) from the previous close of ₹2534.4. The stock opened at ₹2534.4 and traded between ₹2485 and ₹2565, with a total traded volume of 41351 shares. The company has a market capitalization of ₹42934.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3120.7 and ₹2088.1, respectively.
GlaxoSmithKline Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 40.2, EPS of ₹61.15, and book value of ₹17.10. Profitability indicators show ROE of 45.68% along with a dividend yield of 2.2%. GlaxoSmithKline Pharmaceuticals Ltd. has reported revenue of ₹3954.94 Cr and net profit of ₹1068.15 Cr.
GlaxoSmithKline Pharmaceuticals Ltd. technical indicators include Day RSI at 28.52, Day MFI at 65.33, Day ADX at 21.95. Additional indicators include Commodity Channel Index (CCI) at -273.2 and Williams %R at -98.3. Momentum indicators show Day MACD at -48.98, Day MACD Signal Line at -15.42, DayATR at 89.92. Rate of Change indicators for GlaxoSmithKline Pharmaceuticals Ltd. include ROC125 at 7.65 and ROC21 at -14.31.
Exponential moving averages include EMA5 at ₹2661, EMA10 at ₹2724.4, EMA12 at ₹2740.7, EMA20 at ₹2779.5, EMA26 at ₹2789.6, EMA50 at ₹2760.5, EMA100 at ₹2667.8, EMA200 at ₹2606.6. Simple moving averages include SMA5 at ₹2685.5, SMA10 at ₹2752.2, SMA20 at ₹2800.4, SMA30 at ₹2866.5, SMA50 at ₹2810.7, SMA100 at ₹2579.1, SMA150 at ₹2524.1, SMA200 at ₹2512.5.
Support levels for GlaxoSmithKline are placed at First Support ₹2491.57, Second Support ₹2448.73, Third Support ₹2370.97. Resistance levels are seen at First Resistance ₹2612.17, Second Resistance ₹2689.93, Third Resistance ₹2732.77. GlaxoSmithKline Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 4.79%, DII holding at 0%, public holding at 12.42%.
GlaxoSmithKline Performance
Price Movement
₹2485.00
₹2565.00
1 Year Performance
₹2088.10
₹3120.70
Markets Today
Historical Performance
GlaxoSmithKline Fundamentals
GlaxoSmithKline Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 924.42 | 989.15 | 1,022.59 | 973.63 | 804.83 |
| Operating Expense | 631.26 | 641.96 | 655.01 | 638.95 | 554.08 |
| Operating Profit | 293.16 | 347.19 | 367.58 | 334.68 | 250.75 |
| Depreciation | 15.84 | 13.17 | 20.32 | 17.43 | 15.52 |
| Interest | 0.97 | 0.61 | 1.19 | 0.51 | 0.42 |
| Tax | 84.65 | 94.18 | 100.71 | 95.65 | 73.87 |
| Net Profit | 253.33 | 274.94 | 277.18 | 255 | 204.70 |
GlaxoSmithKline Technicals
GlaxoSmithKline Pharmaceuticals Ltd. EMA & SMA
₹2532.10
↗ Bullish Moving Average
2
↘ Bearish Moving Average
14
GlaxoSmithKline Support and Resistance
Resistance
Support
Technical Indicators
GlaxoSmithKline Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 4.5 | 4.9 | 5 | 4.6 | 4.6 | 4.8 |
| DII | 7.8 | 7.7 | 8 | 7.7 | 7.7 | 7.8 |
| Public | 12.7 | 12.4 | 12 | 12.7 | 12.7 | 12.4 |
GlaxoSmithKline Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 27.92 K | 67.3 K | 41.48% |
| Week | 25.83 K | 66.87 K | 38.63% |
| 1 Month | 36.83 K | 81.62 K | 45.13% |
| 6 Month | 70.93 K | 1.24 L | 57.37% |
GlaxoSmithKline SWOT Analysis
Companies with no Debt
Benjamin Graham Value Screen
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter
GlaxoSmithKline Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 May, 2026 | 57 | FINAL | 29 May, 2026 | Equity Share |
| 30 May, 2025 | 42 | FINAL | 30 May, 2025 | Equity Share |
| 07 Nov, 2024 | 12 | INTERIM | 07 Nov, 2024 | Equity Share |
| 31 May, 2024 | 32 | FINAL | 31 May, 2024 | Equity Share |
| 30 Jun, 2023 | 32 | FINAL | 30 Jun, 2023 | Equity Share |
| 07 Jul, 2022 | 60 | SPECIAL | 08 Jul, 2022 | Equity Share |
| 07 Jul, 2022 | 30 | FINAL | 08 Jul, 2022 | Equity Share |
| 19 Jul, 2021 | 30 | FINAL | 20 Jul, 2021 | Equity Share |
| 17 Jul, 2020 | 20 | SPECIAL | 20 Jul, 2020 | Equity Share |
| 17 Jul, 2020 | 20 | FINAL | 20 Jul, 2020 | Equity Share |
GlaxoSmithKline Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,550 | ₹865.90 | ₹1,490.30 | ₹1,835 | ₹2,368.50 | ₹197.15 |
| % Change | 0.95% | -0.76% | -1.02% | -0.89% | -0.48% | 0.37% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 88.20 | 85.30 | 88.40 | 34.70 | 48.10 | -83.40 |
| 1 Year Return | 216.58 | 13.13 | 75.99 | 34 | -3.05 | 1.36 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3160.10
+3.38%
GLAND
Gland Pharma Ltd.
₹ 3058.00
-0.69%
LAURUSLABS
Laurus Labs Ltd.
₹ 2036.60
+1.94%
ALKEM
Alkem Laboratories Ltd.
₹ 5279.00
+0.56%
BIOCON
Biocon Ltd.
₹ 349.40
-0.17%
DIVISLAB
Divi's Laboratories Ltd.
₹ 9340.00
-0.22%
GRANULES
Granules India Ltd.
₹ 814.00
-0.13%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3405.00
-0.89%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1117.50
+0.49%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2293.00
+4.60%
WOCKPHARMA
Wockhardt Ltd.
₹ 2001.00
-1.41%
SHILPAMED
Shilpa Medicare Ltd.
₹ 1025.60
+0.03%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1693.00
+2.92%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1760.00
+0.01%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 20830.00
-0.88%
IPCALAB
Ipca Laboratories Ltd.
₹ 1912.00
-1.36%
ABBOTINDIA
Abbott India Ltd.
₹ 25950.00
+1.45%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4656.90
+0.86%
LUPIN
Lupin Ltd.
₹ 1956.50
+1.01%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1197.00
+1.44%
CIPLA
Cipla Ltd.
₹ 1301.00
-0.44%
FAQ's on GLAXO
What is the current share price of GlaxoSmithKline Pharmaceuticals Ltd.?
What is the Market Capitalization of GlaxoSmithKline Pharmaceuticals Ltd.?
What are the PE and PB ratios for GlaxoSmithKline Pharmaceuticals Ltd.?
What is the 52-Week High and Low for GlaxoSmithKline Pharmaceuticals Ltd.?
What is the current dividend yield for GlaxoSmithKline Pharmaceuticals Ltd.?
Who are the major shareholders of GlaxoSmithKline Pharmaceuticals Ltd.?
Who are the peers of GlaxoSmithKline Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for GlaxoSmithKline Pharmaceuticals Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy